Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities.

Yamazaki H, Shimizu M.

Biochem Pharmacol. 2013 Jun 1;85(11):1588-93. doi: 10.1016/j.bcp.2013.03.020. Epub 2013 Apr 6.

PMID:
23567996
2.

Potential for drug interactions mediated by polymorphic flavin-containing monooxygenase 3 in human livers.

Shimizu M, Shiraishi A, Sato A, Nagashima S, Yamazaki H.

Drug Metab Pharmacokinet. 2015 Feb;30(1):70-4. doi: 10.1016/j.dmpk.2014.09.008. Epub 2014 Oct 5.

PMID:
25760532
3.

Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.

Shimizu M, Kobayashi Y, Hayashi S, Aoki Y, Yamazaki H.

Mol Genet Metab. 2012 Nov;107(3):330-4. doi: 10.1016/j.ymgme.2012.06.014. Epub 2012 Jul 1.

PMID:
22819296
6.

Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.

Zhou J, Shephard EA.

Mutat Res. 2006 Jun;612(3):165-71. Epub 2006 Feb 14. Review.

PMID:
16481213
7.

Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.

Cashman JR, Bi YA, Lin J, Youil R, Knight M, Forrest S, Treacy E.

Chem Res Toxicol. 1997 Aug;10(8):837-41.

PMID:
9282831
8.

Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.

Ferreira F, Esteves S, Almeida LS, Gaspar A, da Costa CD, Janeiro P, Bandeira A, Martins E, Teles EL, Garcia P, Azevedo L, Vilarinho L.

Gene. 2013 Sep 15;527(1):366-70. doi: 10.1016/j.gene.2013.05.025. Epub 2013 Jun 17.

PMID:
23791655
9.

FMO3 allelic variants in Sicilian and Sardinian populations: trimethylaminuria and absence of fish-like body odor.

D'Angelo R, Esposito T, Calabrò M, Rinaldi C, Robledo R, Varriale B, Sidoti A.

Gene. 2013 Feb 25;515(2):410-5. doi: 10.1016/j.gene.2012.12.047. Epub 2012 Dec 21.

PMID:
23266626
10.

Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.

Shimizu M, Yano H, Nagashima S, Murayama N, Zhang J, Cashman JR, Yamazaki H.

Drug Metab Dispos. 2007 Mar;35(3):328-30. Epub 2006 Dec 1.

12.

Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.

Yamazaki H, Fujita H, Gunji T, Zhang J, Kamataki T, Cashman JR, Shimizu M.

Mol Genet Metab. 2007 Jan;90(1):58-63. Epub 2006 Sep 25.

PMID:
16996766
13.
14.

Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.

Motika MS, Zhang J, Zheng X, Riedler K, Cashman JR.

Mol Genet Metab. 2009 Jun;97(2):128-35. doi: 10.1016/j.ymgme.2009.02.006. Epub 2009 Feb 27.

15.
16.

Population-specific polymorphisms of the human FMO3 gene: significance for detoxication.

Cashman JR, Akerman BR, Forrest SM, Treacy EP.

Drug Metab Dispos. 2000 Feb;28(2):169-73.

17.

Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism.

Cashman JR.

Curr Drug Metab. 2000 Sep;1(2):181-91. Review.

PMID:
11465082
18.

Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3.

Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R, Itagaki K, Philpot RM, Rettie AE.

Biochem Pharmacol. 1998 Oct 15;56(8):1005-12.

PMID:
9776311
19.
20.

Trimethylaminuria and a human FMO3 mutation database.

Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, Phillips IR.

Hum Mutat. 2003 Sep;22(3):209-13. Review.

PMID:
12938085
Items per page

Supplemental Content

Write to the Help Desk